Avalon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-10,796
| Closed | -$602K | – | 25 |
|
|
2020
Q1 | $602K | Sell |
10,796
-1,049
| -9% | -$58.5K | 0.71% | 18 |
|
|
2019
Q4 | $760K | Buy |
+11,845
| New | +$760K | 0.92% | 24 |
|
|
2017
Q4 | – | Sell |
-33,907
| Closed | -$2.16M | – | 75 |
|
|
2017
Q3 | $2.16M | Buy |
+33,907
| New | +$2.16M | 1.5% | 21 |
|
|
2016
Q1 | – | Sell |
-18,076
| Closed | -$1.24M | – | 73 |
|
|
2015
Q4 | $1.24M | Buy |
+18,076
| New | +$1.24M | 1.12% | 37 |
|
|
2015
Q3 | – | Sell |
-37,740
| Closed | -$2.51M | – | 60 |
|
|
2015
Q2 | $2.51M | Buy |
+37,740
| New | +$2.51M | 2.29% | 17 |
|
|
2013
Q4 | – | Sell |
-38,566
| Closed | -$1.79M | – | 102 |
|
|
2013
Q3 | $1.79M | Buy |
+38,566
| New | +$1.79M | 1.76% | 14 |
|